CAMBRIDGE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted...
First-Ever Open IND for Prime Editing Technology PM359 is Prime Medicine’s Ex Vivo Product Candidate Designed to Correct a Prevalent...
EMERYVILLE, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop...
THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2024...
TORONTO, April 29, 2024 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company”...
Libervant is the first and only FDA approved orally administered rescue product for the treatment of seizure clusters in patients...
Vaughan, Ontario--(Newsfile Corp. - April 29, 2024) - Delota Corp. (CSE: NIC) (FSE: S62) ("Delota" or the "Company") a leading...
LONDON, UK / ACCESSWIRE / April 29, 2024 / TR-1: Standard form for notification of major holdingsNOTIFICATION OF MAJOR HOLDINGS...
Ibogaine By David Dardashti Creates an Aftercare Support Network for Women Ibogaine support for Women Whitney is excited to help...
Treatment of TBI and Mental Health Disorders in a High Service, Private Oceanside SettingSAN CLEMENTE, CA / ACCESSWIRE / April...
Dividend confirmationRegulated information - 26 april 2024 The general shareholders meeting of 26 April 2024 has approved the annual accounts...
VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 26,...
HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical...
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading...
WATERTOWN, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the “Company” or “Lyra”), a clinical-stage biotech...
TORONTO, April 26, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold...
BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted...
BEIJING, China, April 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc.("Sino Biological" or the "Company”), a biotechnology company listed on...
Comprehensive Treatment of Addiction and Mental Health Requires a Focus on Self-Love Alcohol algorithm New procedures to help those who...